Blood glucose measuring device and blood glucose measuring method
By calculating the time phase difference between oxyhemoglobin and deoxyhemoglobin and estimating the reliability based on the signal-to-noise ratio, and by optimizing the signal using Fourier transform, the problem of noise affecting the accuracy of blood glucose measurement was solved, and high-precision blood glucose measurement was achieved.
Patent Information
- Application Number
- CN202580026587.X
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Priority Date
- 2024-04-11
- Filing Date
- 2025-04-08
- Publication Date
- 2026-11-10
AI Technical Summary
Noise in existing blood glucose measurement devices affects measurement accuracy, resulting in inaccurate readings.
The time phase difference calculation unit calculates the time phase difference between oxyhemoglobin and deoxyhemoglobin, and the reliability estimation unit estimates the reliability of the time phase difference based on the signal-to-noise ratio of the optical detection unit. The signal quality is optimized by combining high-speed Fourier transform, and finally the blood glucose value is calculated by the blood glucose value calculation unit.
It improves the accuracy and reliability of blood glucose measurement, enabling accurate calculation of blood glucose levels even in the presence of noise.
Smart Images

Figure CN123076345A_ABST
Abstract
Description
Technical Field
[0001] This invention relates to a blood glucose measuring device and a blood glucose measuring method. Background Technology
[0002] As a technique for measuring the blood oxygen concentration of an organism, the apparatus described in Patent Document 1 is known, for example. The apparatus described in Patent Document 1 suppresses the decrease in the measurement accuracy of blood oxygen concentration caused by noise by appropriately setting the wavelength of light emitted from multiple light sources.
[0003] Existing technical documents
[0004] Patent documents
[0005] Patent Document 1: Japanese Patent Application Publication No. 2016-2167 Summary of the Invention
[0006] The technical problem that the invention aims to solve
[0007] However, noise can affect the accuracy of blood glucose measurements, thus requiring improvements in the accuracy of blood glucose measurements.
[0008] The purpose of this invention is to provide a blood glucose measuring device and a blood glucose measuring method that can measure blood glucose levels of organisms with high precision.
[0009] Technical solutions for solving technical problems
[0010] The blood glucose measuring device of the present invention is [1] "A blood glucose measuring device for measuring the blood glucose value of an organism, comprising: a light output unit that outputs light to the organism; a light detection unit that detects the light output by the light output unit and transmitted through the organism; a time phase difference calculation unit that calculates the time phase difference between the oxyhemoglobin waveform of the oxyhemoglobin concentration of the blood of the organism and the deoxyhemoglobin waveform of the deoxyhemoglobin concentration of the blood of the organism based on the detection result of the light detection unit; a blood glucose value calculation unit that calculates the blood glucose value of the organism based on the time phase difference calculated by the time phase difference calculation unit; and a reliability estimation unit that estimates the reliability of the time phase difference calculated by the time phase difference calculation unit, wherein the reliability estimation unit estimates the reliability of the time phase difference based on the smaller the SN ratio of the detection result of the light detection unit.
[0011] In the blood glucose measuring device described above [1], the blood glucose calculation unit calculates the blood glucose value of the organism based on the time phase difference between the oxyhemoglobin waveform (resulting in the concentration of oxyhemoglobin in the blood of the organism) and the deoxyhemoglobin waveform (resulting in the concentration of deoxyhemoglobin in the blood of the organism). Therefore, the blood glucose value of the organism can be measured appropriately. Furthermore, the reliability estimation unit estimates that the smaller the SN ratio of the detection result from the photodetector, the smaller the reliability of the time phase difference. Therefore, the blood glucose value can be calculated considering the reliability of the time phase difference. Thus, with this blood glucose measuring device, the blood glucose value of the organism can be measured with high accuracy.
[0012] The blood glucose measuring device of the present invention can also be [2] "the blood glucose measuring device described in [1] above, wherein the time phase difference calculation unit calculates a plurality of time phase differences respectively, the blood glucose value calculation unit calculates a plurality of blood glucose values respectively based on the plurality of time phase differences, and calculates the sum of the series after assigning weights to the plurality of blood glucose values as the representative blood glucose value of the organism, the reliability estimation unit estimates the reliability of each of the plurality of time phase differences, and the smaller the reliability of each of the plurality of time phase differences, the smaller the weight of the blood glucose value calculation unit." Thus, weighting can be performed according to the reliability of the time phase difference, and the blood glucose value of the organism can be measured with high precision.
[0013] The blood glucose measuring device of the present invention can also be [3] "the blood glucose measuring device described in [1] or [2] above, wherein the reliability calculation unit calculates that the time phase difference is highly reliable when the SN ratio is greater than a predetermined threshold, and calculates that the time phase difference is low reliable when the SN ratio is less than or equal to the threshold, wherein the threshold is determined based on the correlation between the error of the time phase difference and the SN ratio and the allowable value of the error of the time phase difference." Thus, the reliability of the time phase difference can be calculated efficiently.
[0014] The blood glucose measuring device of the present invention can also be [4] "the blood glucose measuring device described in any one of [1] to [3] above, wherein the reliability estimation unit calculates the SN ratio based on the spectrum after high-speed Fourier transform of the detection result of the optical detection unit." Thus, the SN ratio can be calculated with high accuracy.
[0015] The blood glucose measuring device of the present invention can also be [5] "the blood glucose measuring device described in [4] above, wherein the reliability calculation unit uses an integer multiple of both the respiratory cycle and the heartbeat cycle of the organism as the period of the high-speed Fourier transform." Thus, the accuracy of the high-speed Fourier transform can be improved.
[0016] The blood glucose measurement method of the present invention is [6] "A blood glucose measurement method for measuring the blood glucose value of an organism, comprising: a time phase difference calculation step, which calculates the time phase difference between the oxyhemoglobin waveform of the oxyhemoglobin concentration of the blood of the organism and the deoxyhemoglobin waveform of the deoxyhemoglobin concentration of the blood of the organism based on the detection result of the light transmitted through the organism; a blood glucose value calculation step, which calculates the blood glucose value of the organism based on the time phase difference calculated in the time phase difference calculation step; and a reliability estimation step, which estimates the reliability of the time phase difference calculated in the time phase difference calculation step, wherein in the reliability estimation step, the smaller the SN ratio of the light detection result, the smaller the reliability of the estimated time phase difference.
[0017] According to the blood glucose measurement method described above [6], the blood glucose measurement device described above can measure the blood glucose value of an organism with high precision.
[0018] The blood glucose measurement method of the present invention can also be [7] "The blood glucose measurement method described in [6] above further includes: a light output step of outputting the light to the organism; and a light detection step of detecting the light output in the light output step and transmitted through the organism." Thus, like the blood glucose measurement device described above, it is possible to measure the blood glucose value of an organism with high precision.
[0019] The effects of the invention
[0020] According to the present invention, a blood glucose measuring device and a blood glucose measuring method capable of measuring blood glucose levels of an organism with high precision can be provided. Attached Figure Description
[0021] Figure 1 This is a conceptual diagram of a blood glucose measurement device according to one implementation method.
[0022] Figure 2 yes Figure 1 The detection results of the photodetector are shown.
[0023] Figure 3 It means Figure 1 The diagram shows the functional structure of the ECU.
[0024] Figure 4 Based on Figure 2 The waveforms of oxyhemoglobin and deoxyhemoglobin calculated from the test results are shown below.
[0025] Figure 5 yes Figure 4 The diagram shows the waveforms of oxyhemoglobin and deoxyhemoglobin.
[0026] Figure 6 yes Figure 4 The diagram shows the waveforms of oxyhemoglobin and deoxyhemoglobin.
[0027] Figure 7 Yes Figure 4 The spectrum of the oxyhemoglobin waveform and the deoxyhemoglobin waveform after high-speed Fourier transform is shown.
[0028] Figure 8 It is a graph showing the correlation between the time phase difference error and the SN ratio.
[0029] Figure 9 It indicates that it is used to obtain Figure 7 The diagram shows the period of the high-speed Fourier transform of the spectrum shown.
[0030] Figure 10 This is a flowchart of the steps involved in a blood glucose measurement method according to one implementation method.
[0031] Figure 11 This is a schematic diagram of the period of the high-speed Fourier transform involved in the variation example. Detailed Implementation
[0032] Hereinafter, embodiments will be described in detail with reference to the accompanying drawings. Furthermore, in each drawing, the same or equivalent parts will be labeled with the same reference numerals, and repeated descriptions will be omitted.
[0033] Figure 1 This is a cross-sectional view of the blood glucose measuring device and the organism in this embodiment. Figure 1 This is merely a conceptual diagram to illustrate the function of the blood glucose measuring device 1, and does not necessarily represent the actual cross-section of the blood glucose measuring device 1.
[0034] Figure 1 The blood glucose measuring device 1 shown is, for example, a wearable device, a smartphone, or a pulse oximeter. Examples of wearable devices include smartwatches and smart rings. In this embodiment, the blood glucose measuring device 1 is a smartwatch with the function of measuring the blood glucose level of an organism 6. The organism 6 has a surface tissue 61 and an internal tissue 62 located further inside the organism 6 than the surface tissue 61. The surface 61a of the surface tissue 61 is the skin surface of the organism 6. The organism 6 is, for example, a human body.
[0035] The blood glucose measuring device 1 measures the blood glucose level of a living organism 6. The blood glucose measuring device 1 includes a main body 2, a light output unit 3, a light detection unit 4, and an ECU (Electronic Control Unit) 5. The main body 2 has a front side 2a and a back side 2b facing the opposite side of the front side 2a. The front side 2a functions as a display screen (monitor) showing various information from the blood glucose measuring device 1. The blood glucose measuring device 1 is mounted on the living organism 6 such that the back side 2b contacts the skin of the living organism 6.
[0036] A light output unit 3 is disposed on the main body 2. The light output surface of the light output unit 3 is exposed from the back surface 2b of the main body 2. The light output unit 3 has a light source for outputting measurement light L to the organism 6. The light source is, for example, a light-emitting diode (LED), a laser diode (LD), or a superluminescent diode (SLD). The measurement light L is emitted from the back surface 2b. After propagating inside the organism 6, the measurement light L emitted from the light output unit 3 is emitted again from the organism 6. The light output unit 3 is controlled by an ECU 5.
[0037] The wavelength range of the measurement light L is, for example, from the red wavelength region of visible light to the near-infrared region (670 nm to 2500 nm). That is, the light output unit 3 outputs the measurement light L, which is contained within the range of the red wavelength region of visible light to the near-infrared region. The light output unit 3 may output measurement lights L with different wavelengths. In this case, the light output unit 3 has multiple (e.g., 3) light sources. The first light source outputs, for example, the measurement light L with a wavelength of 735 nm, the second light source outputs, for example, the measurement light L with a wavelength of 810 nm, and the third light source outputs, for example, the measurement light L with a wavelength of 850 nm. Alternatively, the light output unit 3 may also have a single light source that outputs probe light (e.g., white light) containing different wavelength components.
[0038] A light detection unit 4 is disposed on the main body 2. The light detection unit 4 is spaced apart from the light output unit 3. The light detection surface of the light detection unit 4 is exposed from the back side 2b of the main body 2. The light detection unit 4 has a light detection element that detects the measurement light (transmitted light) L output from the light output unit 3 and transmitted through the biological body 6. The light detection element is, for example, a photodiode (PD). In addition, the light detection unit 4 has a preamplifier that amplifies the photocurrent output from the light detection element and an A / D conversion circuit that converts the signal amplified by the preamplifier into a digital signal. The light detection unit 4 may also have a CCD image sensor or a CMOS image sensor. The light detection unit 4 sends a signal regarding the intensity of the measurement light L to the ECU 5.
[0039] like Figure 2As shown, the photodetector 4 detects at least first data D1 and second data D2. First data D1 is, for example, the time-varying intensity of the transmitted light L with a first wavelength passing through the organism 6 and incident on the photodetector 4; second data D2 is, for example, the time-varying intensity of the transmitted light L with a second wavelength passing through the organism 6 and incident on the photodetector 4. First data D1 and second data D2 change periodically over time. Furthermore, the respective periods of first data D1 and second data D2 are approximately consistent with the heartbeat cycle of the organism 6.
[0040] ECU5 is located in the main body 2. ECU5 is an electronic control unit with storage units such as CPU (Central Processing Unit) and ROM (Read Only Memory) or RAM (Random Access Memory). In ECU5, for example, the CPU executes the program stored in the storage unit. Based on the signal sent from the light detection unit 4 (the detection result of the light detection unit 4), ECU5 calculates the blood glucose level, pulse, and oxygen saturation of the organism 6. Figure 3 This is a block diagram representing the functional structure of ECU5. For example... Figure 3 As shown, ECU5 includes a time phase difference calculation unit 51, a reliability estimation unit 52, and a blood glucose value calculation unit 53.
[0041] Time phase difference calculation unit 51 Figure 4 As shown, based on the detection results of the light detection unit 4, the oxyhemoglobin waveform P1 and the deoxyhemoglobin waveform P2 are calculated. The oxyhemoglobin waveform P1 is data regarding the concentration of oxyhemoglobin (O2Hb) in the blood of organism 6, and the deoxyhemoglobin waveform P2 is data regarding the concentration of deoxyhemoglobin (HHb) in the blood of organism 6. The time phase difference calculation unit 51 performs spectroscopic calculation processing on the first data D1 and the second data D2, for example, based on the Modified Beer-Lambert (MBL) method, thereby calculating the oxyhemoglobin waveform P1 and the deoxyhemoglobin waveform P2.
[0042] Specifically, the time phase difference calculation unit 51 calculates the time-relative change in oxyhemoglobin (ΔO2Hb) and the time-relative change in deoxyhemoglobin (ΔHHb) based on the difference between the intensity of the first data D1 at time 1 and the intensity of the first data D1 at time 2 (the time change in the intensity of the first data D1), the difference between the intensity of the second data D2 at time 1 and the intensity of the second data D2 at time 2 (the time change in the intensity of the second data D2), the absorbance coefficients of oxyhemoglobin and deoxyhemoglobin relative to the first data D1, and the absorbance coefficients of O2Hb and HHb relative to the second data D2. The time phase difference calculation unit 51 continuously calculates ΔO2Hb and ΔHHb at a predetermined time interval (e.g., approximately 16 milliseconds). The time-dependent change in ΔO2Hb is... Figure 4 The oxyhemoglobin waveform P1 shown represents the temporal variation of ΔHHb. Figure 4 The waveform of deoxyhemoglobin shown is P2. Additionally... Figure 4 The concentration index on the vertical axis is, for example, the volume concentration index (concentration × optical path length).
[0043] The time phase difference calculation unit 51 calculates the time phase difference (hereinafter referred to as "time phase difference") between the oxyhemoglobin waveform P1 and the deoxyhemoglobin waveform P2. Figure 5 yes Figure 4 The diagram shows schematic representations of the oxyhemoglobin waveform P1 and the deoxyhemoglobin waveform P2, respectively. The time phase difference calculation unit 51 calculates the time difference Δθ between the first characteristic point C1 of the oxyhemoglobin waveform P1 and the second characteristic point C2 of the deoxyhemoglobin waveform P2. In this embodiment, the first characteristic point C1 is the trough point of the oxyhemoglobin waveform P1, and the second characteristic point C2 is the trough point of the deoxyhemoglobin waveform P2. The first characteristic point C1 may also be, for example, a peak point or a notch point of the oxyhemoglobin waveform P1, and the second characteristic point C2 may also be, for example, a peak point or a notch point of the deoxyhemoglobin waveform P2. In this embodiment, various methods disclosed in Japanese Patent No. 6846152 are used, for example, as methods for calculating the time phase difference Δθ.
[0044] Incidentally, such as Figure 6 As shown, the detection results of the optical detection unit 4 sometimes contain noise, resulting in at least one waveform of oxyhemoglobin P1 and deoxyhemoglobin P2 being affected. Figure 6 The waveform of deoxyhemoglobin (P2) sometimes contains noise. In this case, for example, the extraction of the second feature point C2 of the noisy deoxyhemoglobin waveform P2 becomes unstable, resulting in a decrease in the accuracy of the calculated time phase difference Δθ. This trend is particularly pronounced when the noise amplitude is at the same level as the time phase difference Δθ.
[0045] The reliability estimation unit 52 estimates the reliability of the time phase difference Δθ calculated by the time phase difference calculation unit 51. The reliability estimation unit 52 estimates the reliability of the time phase difference Δθ based on the following principle: the larger the signal-to-noise ratio (SN ratio) of the detection result from the optical detection unit 4 (the smaller the noise level of the detection result from the optical detection unit 4), the greater the reliability of the time phase difference Δθ. Conversely, the reliability estimation unit 52 estimates the reliability of the time phase difference Δθ based on the following principle: the smaller the SN ratio (SN ratio) of the detection result from the optical detection unit 4 (the larger the noise level of the detection result from the optical detection unit 4), the smaller the reliability of the time phase difference Δθ.
[0046] The reliability estimation unit 52 calculates the signal-to-noise ratio (SN ratio) of the detection results of the optical detection unit 4 based on the spectrum obtained by performing a high-speed Fourier transform (FFT) on the detection results of the optical detection unit 4. The high-speed Fourier transform on the detection results of the optical detection unit 4 can be either a direct high-speed Fourier transform performed on the detection results of the optical detection unit 4 or an indirect high-speed Fourier transform performed on the parameters calculated from the detection results of the optical detection unit 4. In this embodiment, the reliability estimation unit 52 is as follows... Figure 7 As shown, high-speed Fourier transforms are performed on the oxyhemoglobin waveform P1 and the deoxyhemoglobin waveform P2, respectively. Figure 7 The first spectrum F1 shown is the power spectrum of the high-speed Fourier transform of the oxyhemoglobin waveform P1, and the second spectrum F2 is the power spectrum of the high-speed Fourier transform of the deoxyhemoglobin waveform P2.
[0047] The first spectrum F1 contains a first dominant peak Pm1 and a first background noise N1. The first dominant peak Pm1 is the lowest frequency peak among all the dominant peaks in the first spectrum F1. The first dominant peak Pm1 is the peak corresponding to the pulse (heart rate peak) of the organism 6. The first background noise N1 is the region in the first spectrum F1 that has a higher frequency than the first dominant peak Pm1 and a lower intensity than the first dominant peak Pm1. The intensity of the first background noise N1 is, for example, the average intensity of the frequency range in the first spectrum F1 that is considered noise.
[0048] The second spectrum F2 comprises a second dominant peak Pm2 and a second background noise N2. The second dominant peak Pm2 is the lowest frequency peak among all the dominant peaks in the second spectrum F2. The second dominant peak Pm2 corresponds to the pulse (heart rate peak) of organism 6. The second background noise N2 is a region in the second spectrum F2 with a frequency higher than that of the second dominant peak Pm2 and a lower intensity than that of the second dominant peak Pm2. The intensity of the second background noise N2 is, for example, the average intensity of the frequency range in the second spectrum F2 that is considered noise. Figure 7 The first spectrum F1 and the second spectrum F2 shown are normalized in such a way that the first dominant peak Pm1 of the first spectrum F1 is consistent with the second dominant peak Pm2 of the second spectrum F2.
[0049] The reliability estimation unit 52 identifies the first difference W1 between the first dominant peak Pm1 and the first background noise N1 as the SN ratio of the first spectrum F1 (the SN ratio of the detection result of the photodetector 4), and identifies the second difference W2 between the second dominant peak Pm2 and the second background noise N2 as the SN ratio of the second spectrum F2 (the SN ratio of the detection result of the photodetector 4). The reliability estimation unit 52 estimates that the greater the SN ratio of the first spectrum F1 (first difference W1) and the SN ratio of the second spectrum F2 (second difference W2), the greater the reliability of the time phase difference Δθ. The reliability estimation unit 52 estimates that the smaller the SN ratio of the first spectrum F1 and the SN ratio of the second spectrum F2, the smaller the reliability of the time phase difference Δθ.
[0050] In this embodiment, the reliability estimation unit 52 estimates that the time phase difference Δθ is of high reliability when both the SN ratio of the first spectrum F1 and the SN ratio of the second spectrum F2 are greater than a predetermined threshold, and estimates that the time phase difference Δθ is of low reliability when at least one of the SN ratios of the first spectrum F1 and the second spectrum F2 is less than or equal to the aforementioned threshold. The threshold is determined, for example, based on the correlation between the error of the time phase difference Δθ and the SN ratio and the allowable value of the error of the time phase difference Δθ.
[0051] Figure 8 This is a graph showing the correlation between the error of the time phase difference Δθ and the SN ratio. In this embodiment, this correlation is calculated numerically. Specifically, firstly, after applying a specified noise to both the first spectrum F1 and the second spectrum F2 (noise-free spectra), the difference in time phase difference Δθ before and after the noise is applied is calculated multiple times (e.g., 1000 times). Next, the standard deviation of the multiple differences is calculated as the error of the time phase difference Δθ. Then, while changing the noise level, the errors of multiple time phase differences Δθ corresponding to multiple SN ratios are calculated.
[0052] Figure 8 The first correlation R1 shown is the correlation between the error (1σ) of the time phase difference Δθ and the SN ratio. Figure 8 The second correlation R2 shown is the correlation between the error (3σ) of the time phase difference Δθ and the SN ratio. In this embodiment, the SN ratio corresponding to the intersection of the first correlation R1 and the allowable value T of the error of the time phase difference Δθ is the first threshold S1, and the SN ratio corresponding to the intersection of the second correlation R2 and the allowable value T is the second threshold S2. The first threshold S1 is less than the second threshold S2. The allowable value T of the error of the time phase difference Δθ is calculated, for example, based on the allowable value of the measurement error of the blood glucose value (e.g., the ISO recommendation value), using the blood glucose value calculation formula described later.
[0053] The reliability calculation unit 52 calculates that the time phase difference Δθ is of high reliability when both the SN ratio of the first spectrum F1 and the SN ratio of the second spectrum F2 are greater than the first threshold S1 or the second threshold S2. Conversely, if at least one of the SN ratios of the first spectrum F1 and the second spectrum F2 is less than or equal to the first threshold S1 or the second threshold S2, the time phase difference Δθ is calculated as of low reliability. When both the SN ratios of the first spectrum F1 and the second spectrum F2 are greater than the first threshold S1, the probability that the time phase difference Δθ is of high reliability is 68%. When both the SN ratios of the first spectrum F1 and the second spectrum F2 are greater than the second threshold S2, the probability that the time phase difference Δθ is of high reliability is 99.7%. The reliability calculation unit 52 can use either the first threshold S1 or the second threshold S2 based on the measurement accuracy requirements of the blood glucose value. In addition, the first correlation R1 and the second correlation R2 are pre-stored in the storage section of the blood glucose measuring device 1.
[0054] The reliability calculation unit 52 uses an integer multiple of both the respiratory cycle and the heartbeat cycle of the organism 6 as the period of the aforementioned high-speed Fourier transform. Figure 9 This is a schematic diagram representing the period of a high-speed Fourier transform. Figure 9 The diagram shows the oxyhemoglobin waveform P1 and the respiratory waveform B of organism 6. Respiratory waveform B increases according to the inhalation of organism 6 and then decreases according to the exhalation of organism 6. The period of respiratory waveform B (the respiratory cycle of organism 6) is several times longer than the period of oxyhemoglobin waveform P1 (the heartbeat cycle of organism 6). The entire oxyhemoglobin waveform P1 changes with respiratory waveform B, and the trough of oxyhemoglobin waveform P1 overlaps with respiratory waveform B. That is, the oxyhemoglobin waveform P1 overlaps with a surge component composed of the respiratory cycle of organism 6.
[0055] To ensure the accuracy of the high-speed Fourier transform (HST) of the oxyhemoglobin waveform P1, the amplitude of the starting point Ps of the oxyhemoglobin waveform P1 used for the HST must be consistent with the amplitude of the ending point Pe. When the period of the HST is an integer multiple of both the respiratory cycle and the heartbeat cycle of the organism 6, that is, when a region in the oxyhemoglobin waveform P1 that is an integer multiple of both the respiratory cycle and the heartbeat cycle of the organism 6 is extracted, the amplitude of the starting point Ps of the oxyhemoglobin waveform P1 is easily consistent with the amplitude of the ending point Pe. The reliability calculation unit 52 takes the intersection point of the oxyhemoglobin waveform P1 with the respiratory waveform B as the starting point Ps, extracts a region in the oxyhemoglobin waveform P1 that is an integer multiple of the period of the respiratory waveform B, and performs the HST. In this embodiment, the reliability calculation unit 52 takes the intersection point of the trough point of the respiratory waveform B and the trough point of the oxyhemoglobin waveform P1 as the starting point Ps or the ending point Pe of the oxyhemoglobin waveform P1. That is, the reliability estimation unit 52 extracts the region between two adjacent intersection points in the oxyhemoglobin waveform P1 and performs a high-speed Fourier transform. The reliability estimation unit 52 also performs a high-speed Fourier transform on the deoxyhemoglobin waveform P2 with the same period.
[0056] The blood glucose calculation unit 53 calculates the blood glucose value of the organism 6 based on the time phase difference Δθ calculated by the time phase difference calculation unit 51. The blood glucose calculation unit 53 calculates the blood glucose value of the organism 6 using the formula G = α × Δθ - β. Here, G is the blood glucose value of the organism 6, Δθ is the time phase difference, and α and β are coefficients determined based on the organism 6's glucose metabolism capacity and the measurement site, respectively. In this embodiment, various methods disclosed in Japanese Patent No. 6846152 are used, for example, as methods for calculating the blood glucose value.
[0057] The blood glucose calculation unit 53 calculates a representative blood glucose value for the organism 6. Specifically, the time phase difference calculation unit 51 calculates multiple time phase differences, such as a first time phase difference Δθ1 and a second time phase difference Δθ2. The reliability estimation unit 52 estimates the reliability of each of the multiple time phase differences, such as the reliability of the first time phase difference Δθ1 and the reliability of the second time phase difference Δθ2. The blood glucose calculation unit 53 calculates multiple blood glucose values based on the multiple time phase differences. For example, the blood glucose calculation unit 53 calculates a first blood glucose value G1 based on the first time phase difference Δθ1 and a second blood glucose value G2 based on the second time phase difference Δθ2.
[0058] The blood glucose calculation unit 53 calculates the sum of the weighted series of the first blood glucose value G1 and the second blood glucose value G2 as the representative blood glucose value G of the organism 6. The blood glucose calculation unit 53 calculates the representative blood glucose value of the organism 6 using, for example, the formula G = G1 × f1 + G2 × f2. Here, G is the representative blood glucose value, G1 is the first blood glucose value, G2 is the second blood glucose value, f1 is the first weight, and f2 is the second weight. That is, the blood glucose calculation unit 53 assigns the first weight f1 to the first blood glucose value G1 and the second weight f2 to the second blood glucose value G2. The blood glucose calculation unit 53 assigns a smaller weight to the time phase difference as its reliability decreases. For example, when the reliability of the first time phase difference Δθ1 is less than the reliability of the second time phase difference Δθ2, the blood glucose calculation unit 53 makes the first weight f1 less than the second weight f2. For example, when the reliability of the first time phase difference Δθ1 is greater than or equal to the reliability of the second time phase difference Δθ2, the blood glucose value calculation unit 53 makes the first weight f1 greater than or equal to the second weight f2.
[0059] The blood glucose calculation unit 53 may also set either the first weight f1 or the second weight f2 to zero. That is, the blood glucose calculation unit 53 may also discard either the first blood glucose value G1 or the second blood glucose value G2. The blood glucose calculation unit 53 may also discard the blood glucose value calculated based on the aforementioned low-reliability time phase difference.
[0060] Next, the blood glucose measurement method of this embodiment will be described. For example... Figure 10 As shown, in the blood glucose measurement method of this embodiment, firstly, a measurement light L is output to the organism 6 (step S1). Step S1 corresponds to the light output step. Next, the measurement light L output in step S1 and transmitted through the organism 6 is detected (step S2). Step S2 corresponds to the light detection step. Next, based on the detection result of the measurement light L transmitted through the organism 6, the time phase difference Δθ between the oxyhemoglobin waveform P1 and the deoxyhemoglobin waveform P2 is calculated (step S3). Step S3 corresponds to the time phase difference calculation step. In step S3 of this embodiment, the first time phase difference Δθ1 and the second time phase difference Δθ2 are calculated. Next, the reliability of each of the first time phase difference Δθ1 and the second time phase difference Δθ2 calculated in step S3 is estimated (step S4). Step S4 corresponds to the reliability estimation step. In step S4, the smaller the SN ratio of the detection result of the measurement light L, the smaller the reliability of the estimated time phase difference.
[0061] Next, based on the time phase difference calculated in step S3, the blood glucose value of organism 6 is calculated (step S5). In this embodiment, in step S3, a first blood glucose value G1 is calculated based on a first time phase difference Δθ1, and a second blood glucose value G2 is calculated based on a second time phase difference Δθ2. Then, the sum of the weighted series of the first blood glucose value G1 and the second blood glucose value G2 is calculated as the representative blood glucose value of organism 6 (step S6). In step S6, the sum of the first blood glucose value G1 (G1×f1) assigned a first weight f1 and the second blood glucose value G2 (G2×f2) assigned a second weight f2 is calculated. In step S6, for example, if the reliability of the first time phase difference Δθ1 is less than the reliability of the second time phase difference Δθ2, the first weight f1 is made less than the second weight f2; for example, if the reliability of the first time phase difference Δθ1 is greater than or equal to the reliability of the second time phase difference Δθ2, the first weight f1 is made greater than or equal to the second weight f2. Steps S5 and S6 are equivalent to blood glucose value calculation steps.
[0062] As described above, in the blood glucose measuring device 1 of this embodiment, the blood glucose calculation unit 53 calculates the blood glucose value of the organism 6 based on the time phase difference Δθ between the oxyhemoglobin waveform P1 (resulting in the concentration of oxyhemoglobin in the blood of the organism 6) and the deoxyhemoglobin waveform P2 (resulting in the concentration of deoxyhemoglobin in the blood of the organism 6). Therefore, the blood glucose value of the organism 6 can be measured appropriately. Furthermore, the reliability estimation unit 52 estimates the reliability of the time phase difference Δθ based on the smaller the SN ratio of the detection result from the photodetector 4. Therefore, the blood glucose value can be calculated considering the reliability of the time phase difference Δθ. Thus, the blood glucose measuring device 1 can measure the blood glucose value of the organism 6 with high accuracy.
[0063] The blood glucose calculation unit 53 calculates a first blood glucose value G1 based on a first time phase difference Δθ1, and a second blood glucose value G2 based on a second time phase difference Δθ2. The blood glucose calculation unit 53 calculates the sum of the weighted series of the first and second time phase differences Δθ1 and Δθ2 respectively, as the representative blood glucose value of the organism 6. The reliability estimation unit 52 estimates the reliability of each of the first and second time phase differences Δθ1 and Δθ2. The blood glucose calculation unit 53 assigns a smaller weight to each time phase difference as its reliability decreases. Therefore, by weighting based on the reliability of the time phase differences, the blood glucose value of the organism 6 can be measured with high accuracy.
[0064] The reliability estimation unit 52 estimates the time phase difference Δθ to be of high reliability when both the SN ratio of the first spectrum F1 and the SN ratio of the second spectrum F2 are greater than the first threshold S1 or the second threshold S2; and estimates the time phase difference Δθ to be of low reliability when at least one of the SN ratios of the first spectrum F1 and the second spectrum F2 is less than or equal to the first threshold S1 or the second threshold S2. The first threshold S1 or the second threshold S2 is determined based on the correlation between the error of the time phase difference Δθ and the SN ratio and the allowable value T of the error of the time phase difference Δθ. Therefore, the reliability of the time phase difference Δθ can be estimated efficiently.
[0065] The reliability estimation unit 52 calculates the SN ratio based on the spectrum obtained from the high-speed Fourier transform of the detection results of the optical detection unit 4. This allows for the calculation of the SN ratio with high accuracy.
[0066] The reliability estimation unit 52 uses integer multiples of both the respiratory cycle and the heartbeat cycle of the organism 6 as the period of the high-speed Fourier transform. This improves the accuracy of the high-speed Fourier transform.
[0067] The blood glucose measurement method according to this embodiment, like the blood glucose measurement device 1, can measure the blood glucose value of an organism 6 with high precision.
[0068] The above describes one embodiment of the present invention, but the present invention is not limited to the above embodiment.
[0069] In one implementation, the reliability estimation unit 52 uses the intersection of the trough of the respiratory waveform B and the trough of the oxyhemoglobin waveform P1 as the starting point Ps of the oxyhemoglobin waveform P1 for high-speed Fourier transform. However, the reliability estimation unit 52 can also perform a high-speed Fourier transform as follows: Figure 11 As shown, any intersection point between the oxyhemoglobin waveform P1 and the respiratory waveform B is taken as the starting point Ps for high-speed Fourier transform. In this case, the amplitude of the starting point Ps of the oxyhemoglobin waveform P1 is also likely to be consistent with the amplitude of the ending point Pe, thus ensuring the accuracy of the high-speed Fourier transform.
[0070] In one embodiment, the reliability estimation unit 52 calculates the SN ratio of the photodetector 4 by performing high-speed Fourier transform on the oxyhemoglobin waveform P1 and the deoxyhemoglobin waveform P2 respectively. However, the reliability estimation unit 52 can also calculate the SN ratio of the photodetector 4 by performing high-speed Fourier transform on the first data D1 and the second data D2 respectively.
[0071] In this embodiment, the ECU5 is installed in the main body 2, but the ECU5 may also be installed outside the main body 2. For example, the ECU5 may be installed in a server or similar device capable of communicating with the main body 2. In this case, the main body 2, the light output unit 3, the light detection unit 4, and the ECU5 are each components of the blood glucose measurement system.
[0072] In addition to the first data D1 and the second data D2, the light detection unit 4 can also detect a third data. The time phase difference calculation unit 51 can also calculate multiple (3) time phase differences based on the first data D1, the second data D2, and the third data. The blood glucose value calculation unit 53 can, for example, calculate the blood glucose value of the organism 6 based on the average of the above three time phase differences.
[0073] The blood glucose calculation unit 53 can also calculate the time-dependent change in the representative blood glucose value G. If a low-reliability representative blood glucose value G is calculated based on a low-reliability time phase difference, the blood glucose calculation unit 53 can discard that low-reliability representative blood glucose value G. In this case, the blood glucose calculation unit 53 can also use the representative blood glucose values G before and after the low-reliability representative blood glucose value G to complete the representative blood glucose value for the time corresponding to the low-reliability representative blood glucose value G. For example, the blood glucose calculation unit 53 can also calculate the average of the representative blood glucose values G before and after the low-reliability representative blood glucose value G as the representative blood glucose value for the time corresponding to the low-reliability representative blood glucose value G.
[0074] The blood glucose calculation unit 53 can also calculate blood glucose values multiple times and calculate the average of multiple blood glucose values as a representative blood glucose value G. The blood glucose calculation unit 53 can also increase the number of blood glucose value calculations when the reliability of each time phase difference is relatively small. Therefore, even if there is a time phase difference with relatively low reliability among the multiple time phase differences used to calculate the representative blood glucose value G, the measurement accuracy of the representative blood glucose value G can be ensured.
[0075] The ECU5 may also include a notification unit as a functional structure. The notification unit displays the reliability of the blood glucose value along with the blood glucose value on the display screen of the main body 2. For example, the notification unit 55 may also display icons on the display screen of the main body 2 that represent the time-varying changes of the blood glucose value G and the magnitude of the reliability of the blood glucose value G at each time point (the reliability of the time phase difference).
[0076] Explanation of reference numerals in the attached figures
[0077] 1. Blood glucose measuring device
[0078] 3. Light Output Section
[0079] 4. Optical Detection Unit
[0080] 6. Organisms
[0081] 51 Time Phase Difference Calculation Unit
[0082] 52 Reliability Estimation Department
[0083] 53 Blood Glucose Calculation Department
[0084] F1 First Spectrum
[0085] F2 Second Spectrum
[0086] L Measuring light
[0087] P1 Oxyhemoglobin waveform
[0088] P2 deoxyhemoglobin waveform
[0089] S1 First Threshold
[0090] S2 Second Threshold
[0091] T tolerance value
[0092] Δθ is the time phase difference.
Claims
1. A blood glucose measuring device for measuring blood glucose levels in an organism, characterized in that, include: The light output unit outputs light to the organism; A light detection unit that detects the light output from the light output unit that passes through the organism; The time phase difference calculation unit calculates the time phase difference between the oxyhemoglobin waveform with respect to the oxyhemoglobin concentration of the blood of the organism and the deoxyhemoglobin waveform with respect to the deoxyhemoglobin concentration of the blood of the organism, based on the detection result of the photodetector. A blood glucose value calculation unit calculates the blood glucose value of the organism based on the time phase difference calculated by the time phase difference calculation unit; and The reliability estimation unit estimates the reliability of the time phase difference calculated by the time phase difference calculation unit. The reliability estimation unit estimates the reliability of the time phase difference based on the smaller the SN ratio of the detection results of the optical detection unit.
2. The blood glucose measuring device as described in claim 1, characterized in that: The time phase difference calculation unit calculates multiple time phase differences, which are respectively the time phase differences. The blood glucose calculation unit calculates multiple blood glucose values, each representing a different time phase difference, and then calculates the sum of a series of values after assigning weights to each of the multiple blood glucose values as the representative blood glucose value of the organism. The reliability estimation unit estimates the reliability of each of the plurality of time phase differences. The blood glucose calculation unit causes the weight to decrease as the reliability of each of the plurality of time phase differences decreases.
3. The blood glucose measuring device as described in claim 1, characterized in that: The reliability estimation unit estimates the time phase difference as having high reliability when the SN ratio is greater than a predetermined threshold, and estimates the time phase difference as having low reliability when the SN ratio is less than or equal to the threshold. The threshold is determined based on the correlation between the error of the time phase difference and the SN ratio, and the allowable value of the error of the time phase difference.
4. The blood glucose measuring device as described in claim 1, characterized in that: The reliability estimation unit calculates the SN ratio based on the spectrum of the high-speed Fourier transform of the detection results of the optical detection unit.
5. The blood glucose measuring device as described in claim 4, characterized in that: The reliability estimation unit uses an integer multiple of both the organism's respiratory cycle and heartbeat cycle as the period of the high-speed Fourier transform.
6. A method for measuring blood glucose levels in an organism, characterized in that, include: The time phase difference calculation step involves calculating the time phase difference between the oxyhemoglobin waveform (related to the concentration of oxyhemoglobin in the blood of the organism) and the deoxyhemoglobin waveform (related to the concentration of deoxyhemoglobin in the blood of the organism) based on the detection results of the light transmitted through the organism. The blood glucose value calculation step calculates the blood glucose value of the organism based on the time phase difference calculated in the time phase difference calculation step. and The reliability estimation step estimates the reliability of the time phase difference calculated in the time phase difference calculation step. In the reliability estimation step, the smaller the SN ratio of the light detection result, the lower the reliability of the estimated time phase difference.
7. The blood glucose measurement method as described in claim 6, characterized in that, Also includes: The light output step of outputting the light to the organism; and The light detection step is used to detect the light output in the light output step and the light transmitted through the organism.
Citation Information
Patent Citations
Wrist fitting type pulse oximeter
JP2016002167A
